Report this service

CROACCESS SERVICE PROFILE

Screening and Lead Identification — Selvita

0.0 (0 Reviews)
43 Views
Scope with confidence. Review the published service details, then contact the CRO directly to confirm methods, timing, availability, and pricing.
  • Response Time
    Contact CRO
  • Delivery Time
    Project dependent
  • Location

About this service

Screening and Lead Identification — Selvita

At Selvita, we approach screening and lead identification as a decision-focused engagement, not a disconnected list of tasks. Before work begins, we clarify the scientific or operational question, the materials and information already available, the constraints that could affect execution, and the evidence your team needs at the end. That alignment lets us build a practical scope for screening and lead identification while keeping the work connected to the broader program.

Our screening and lead identification capabilities

We approach screening and lead identification by defining success before the first activity starts. We use early scoping to build a sharper request, review the proposed approach, and agree what a decision-ready result will look like. The goal is to find and validate tractable starting points with evidence strong enough to guide investment. Our project plan explains how the work will produce evidence for which hits or candidates should advance, be redesigned, or stop, including what will happen if results fall outside expectations. Early alignment on inputs, assumptions, responsibilities, and review gates is often the difference between useful evidence and an expensive activity report. Give our team enough non-confidential context to challenge assumptions, identify dependencies, and recommend a realistic path. We are a fully-integrated contract research organization headquartered in Kraków, Poland, with additional operations in San Francisco. They provide multidisciplinary drug discovery, development, and contract testing services spanning medicinal chemistry, biology, DMPK, computational chemistry, and in vitro/in vivo pharmacology, supporting clients from hit identification through preclinical candidate selection. This context helps establish potential fit. Final selection should depend on project-specific evidence: the proposed scientific lead, relevant examples, methods, capacity, quality status, and timeline. Share the program context, available evidence, constraints, and the decision deadline. Resolve material gaps before the scope and quotation are finalized. Agree the methods, responsibilities, dependencies, controls, acceptance criteria, review points, and change process in one executable plan. Run the work against named milestones. This work sits within our Pre-Clinical Research capabilities and is coordinated with the wider program context when the scope requires it.

  • Assay format, controls, library or modality, and throughput.

How we shape the scope

A strong scope makes the work easier to execute and easier to evaluate. We document the core question, required inputs, proposed activities, review points, and expected outputs, then connect each element to a program need. Where multiple approaches could be reasonable, we explain the tradeoffs and agree how the choice will be made. That discipline helps protect timelines while giving the technical team room to respond to the evidence.

Working with Selvita

Our team treats communication as part of the technical service. We establish contacts, review points, and escalation paths at the outset, then use them to keep decisions moving. Interim conversations distinguish confirmed findings from working interpretations and unresolved questions. That separation is important: it lets the program team act with appropriate confidence while giving specialists space to investigate observations that require more context.

Deliverables built for the next decision

We define deliverables before execution so the final package supports its intended use. Depending on the agreed scope, that may include data files, methods or workflow documentation, quality records, summaries, figures, or a decision-focused report; only the items relevant to this service are included. We review format, level of detail, and downstream users in advance. Final discussions cover what was done, what was observed, how results should be interpreted, and which questions remain outside the evidence generated.

Planning your screening and lead identification project with Selvita

To plan a screening and lead identification project, share the program stage, primary objective, available inputs, known constraints, desired timing, and the decision the work needs to support. We will use that information to frame a focused technical discussion and return a scope that identifies the proposed approach, responsibilities, assumptions, review points, deliverables, and major cost or schedule drivers.

Common questions

What can be included in screening and lead identification?

The proposed scope centers on screening workflows and data review supporting lead identification. Exact activities, methods, inputs, outputs, and responsibilities are confirmed with Selvita for the specific program.

Timing and pricing depend on project stage, complexity, required methods, available inputs, locations, quality requirements, and deliverables. Request a quote from the CRO after sharing a non-confidential project outline.

ONE PLATFORM. THREE WAYS TO MOVE FORWARD.

The right CRO is only part of the decision.

CROaccess helps life science teams move from an open-ended search to a confident partner decision. Choose the level of support that fits your program and your team.

1

Explore

Search CRO profiles and published service listings independently.

2

Match

Describe your program and receive recommendations aligned with services, stage, and location.

3

Partner

Get hands-on support through outreach, comparison, proposal review, and CRO selection.

Official-source researchClear service comparisonsDirect CRO contact